This Article contains errors in the legend of Figure 5.
“(A) Systemic zinc chloride (ZnCl2; i.p. 1 mg/kg) significantly inhibited NaHS-induced scratching. (B) Local application of ZnCl2 (i.d. 5 nmol) significantly inhibited NaHS-induced scratching in both RTX- and vehicle-treated mice. (C) ZnCl2 (i.d. 5 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (D) ZnCl2(i.pl. 5 nmol) significantly inhibited NaHS-induced flinching. (E) Systemic ascorbic acid (Asc; i.p. 1 mg/kg) significantly inhibited NaHS-induced scratching. (F) Asc (i.d. 1 nmol) significantly inhibited NaHS-induced scratching in both RTX- and vehicle-treated mice. (G) Asc (i.d. 1 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (H) Asc (i.pl. 1 nmol) significantly inhibited NaHS-induced flinching. (I) Local application of mibefradil (Mib) (i.d. 5–25 nmol) dose-dependently inhibited NaHS-induced scratching in mice. (J) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced scratching in RTX-treated mice. (K) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (L) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced flinching. All data are expressed by means ± SEM. n = 6–8 mice per group. *P < 0.05; **P < 0.01, ***P < 0.001 vs. vehicle control, Student’s t test”.
should read:
“(A) Local application of mibefradil (Mib) (i.d. 5–25 nmol) dose-dependently inhibited NaHS-induced scratching in mice. (B) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced scratching in RTX-treated mice. (C) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (D) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced flinching. (E) Systemic zinc chloride (ZnCl2; i.p. 1 mg/kg) significantly inhibited NaHS-induced scratching. (F) Local application of ZnCl2 (i.d. 5 nmol) significantly inhibited NaHS-induced scratching in both RTX- and vehicle-treated mice. (G) ZnCl2 (i.d. 5 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (H) ZnCl2 (i.pl. 5 nmol) significantly inhibited NaHS-induced flinching. (I) Systemic ascorbic acid (Asc; i.p. 1 mg/kg) significantly inhibited NaHS-induced scratching. (J) Asc (i.d. 1 nmol) significantly inhibited NaHS-induced scratching in both RTX- and vehicle-treated mice. (K) Asc (i.d. 1 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (L) Asc (i.pl. 1 nmol) significantly inhibited NaHS-induced flinching. All data are expressed by means ± SEM. n = 6–8 mice per group. *P < 0.05; **P < 0.01, ***P < 0.001 vs. vehicle control, Student’s t test”.
Additional information
The online version of the original article can be found at 10.1038/srep16768
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Wang, XL., Tian, B., Huang, Y. et al. Correction: Corrigendum: Hydrogen sulfide-induced itch requires activation of Cav3.2 T-type calcium channel in mice. Sci Rep 7, 46906 (2017). https://doi.org/10.1038/srep46906
Published:
DOI: https://doi.org/10.1038/srep46906
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
